<DOC>
	<DOCNO>NCT02444169</DOCNO>
	<brief_summary>A retrospective study evaluate Ulthera® System potential interaction toxins filler . Up 500 subject enrol .</brief_summary>
	<brief_title>Retrospective Evaluation Combination Treatment With Ulthera System</brief_title>
	<detailed_description>This retrospective , multi‐site study involve chart review subject receive Ultherapy treatment along Radiesse® , Xeomin® , and/or Belotero® Balance within six month apart face and/or neck area . Enrolled subject receive Ultherapy treatment along botulinum toxin A and/or filler treatment ( ) within last two year filler toxin treatment occur within 6 month Ultherapy .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Male female , age 25 70 year . Subject good health Subject must Ultherapy treatment Merz brand neurotoxin/filler treatment within 6 month one Ultherapy treatment . Subject must Ultherapy neurotoxin/filler within last 2 year ( since April 2013 ) toxin/filler treatment within 6 month proximity Ultherapy treatment date . Absence physical psychological condition unacceptable investigator , especially contraindicate receive treatment Ultherapy , Belotero , Radiesse and/or Xeomin . Subjects identify good photography , must ability contact provide authorization disclose photographs usage previously take photography , photo deem worthy publication . Subjects Ultherapy treatment ( ) April 2013 . Subjects receive Radiesse® , Xeomin® , and/or Belotero Balance® within 6 month Ultherapy treatment date . Psychiatric drug and/or disease investigator opinion would impair subject understanding photo consent , photo choose publication .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>